A week after Disney and Universal filed a landmark lawsuit against Midjourney, the generative AI startup’s new V1 video tool will make clips of Shrek, Deadpool, and other famous creations.

Outro, which is now available in seven states, wants to help people taper off antidepressants without experiencing debilitating side effects.

Politico has rules about AI in the newsroom. Staffers say those rules have been violated—and they’re gearing up for a fight.

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.

The acting head of the General Services Administration says it has no DOGE team. It merely lists at least a half-dozen DOGE affiliates on payroll and has a section of its building for DOGE use only.

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.